The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib trial of cabazitaxel and tasquinimod in men with heavily pretreated metastatic castration resistant prostate cancer (mCRPC): The CATCH trial.
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Patrick Healy
No Relationships to Disclose
 
Russell Zelig Szmulewitz
Consulting or Advisory Role - Bayer; Pfizer
Research Funding - Active Biotech (Inst)
 
Carolyn Winters
No Relationships to Disclose
 
Michael Roger Harrison
Speakers' Bureau - Dendreon; NanoCarrier
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Pfizer (Inst)
 
Elia Martinez
No Relationships to Disclose
 
Kelly Mundy
No Relationships to Disclose
 
Susan Halabi
Honoraria - Oncogenex; Sanofi
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Daniel J. George
Honoraria - Bayer; Dendreon; Medivation; Novartis; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; BIND Biosciences; Dendreon; Exelixis; GlaxoSmithKline; Innocrin Pharma; Medivation; Novartis; Pfizer; Sanofi
Speakers' Bureau - Dendreon; Novartis; Sanofi
Research Funding - Acerta Pharma; Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Novartis; Pfizer; Sanofi